Literature DB >> 2540114

Experimental infection of rhesus monkeys with SIV isolated from African green monkeys.

O Herchenröder1, C Stahl-Hennig, W Lüke, J Schneider, G Schulze, H Hartmann, H Schmidt, K Tenner-Racz, P Racz, M Hayami.   

Abstract

To establish an animal model for AIDS, 6 juvenile rhesus monkeys were infected intravenously with cell-free SIVagmTYO-1, 5, or 7. One animal was infected with SIV of known pathogenicity isolated from a sooty mangabey (SIVsmm). The 2 animals infected with TYO-1, 1 of 2 infected with TYO-7 and the 1 infected with SIVsmm seroconverted within 4-8 weeks after infection and infectious virus could be recovered 8-10 or 44 weeks after infection. Three of the 4 seroconverted monkeys developed a persistent lymphadenopathy 12 weeks after infection. Rhesus monkeys infected with SIVagm could serve as a model to study HIV infection and for vaccine trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540114     DOI: 10.1159/000150126

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  4 in total

1.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Inactivation of simian immunodeficiency virus by hydrostatic pressure.

Authors:  E Jurkiewicz; M Villas-Boas; J L Silva; G Weber; G Hunsmann; R M Clegg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

3.  Fidelity of reverse transcriptase of the simian immunodeficiency virus from African green monkey.

Authors:  A Manns; H König; M Baier; R Kurth; F Grosse
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

4.  Restriction of multiple divergent retroviruses by Lv1 and Ref1.

Authors:  Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Paul D Bieniasz; Greg J Towers
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.